In the original version of this article (1), Fig. 2C was mislabeled by the compositor during production of the paper and should read: soto-p5/A02 KD = 14.0 nmol/L. Figure 2C has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
Reference
- 1. Hattori T, Maso L, Araki KY, Koide A, Hayman J, Akkapeddi P, et al. Creating MHC-restricted neoantigens with covalent inhibitors that can be targeted by immune therapy. Cancer Discov 2023;13:132–45. [DOI] [PMC free article] [PubMed] [Google Scholar]